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The transport and ion-coupling mechanisms of ZIP trans-
porters remain largely uncharacterized. Previous work in our
laboratory has revealed that the solute carrier family 39member
A2 (SLC39A2/ZIP2) increases its substrate transport rate in the
presence of extracellular H. Here, we used a combination of in
silico and in vitro techniques involving structural modeling,
mutagenesis, and functional characterization in HEK293 cells
to identify amino acid residues potentially relevant for both the
ZIP2–H interaction and substrate binding. Our ZIP2 models
revealed a cluster of charged residues close to the substrate–
translocation pore. Interestingly, the H63A substitution com-
pletely abrogated pH sensitivity, and substitutions of Glu-67
and Phe-269 altered the pH and voltage modulation of trans-
port. In contrast, substitutionofGlu-106,whichmight bepart of
a dimerization interface, altered pHbut not voltagemodulation.
Substitution of Phe-269, located close to the substrate-binding
site, also affected substrate selectivity. These findings were sup-
ported by an additional model of ZIP2 that was based on the
structure of a prokaryotic homolog, Bordetella bronchiseptica
ZrT/Irt-like protein (bbZIP), and in silico pKa calculations. We
also found that residuesGlu-179,His-175,His-202, andGlu-276
are directly involved in the coordination of the substrate metal
ion. We noted that, unlike bbZIP, human ZIP2 is predicted to
harbor a single divalent metal-binding site, with the charged
side chain of Lys-203 replacing the second bound ion. Our
results provide the first structural evidence for the previously
observed pH and voltage modulation of ZIP2-mediated metal
transport, identify the substrate-binding site, and suggest a
structure-based transport mechanism for the ZIP2 transporter.
Zinc (Zn2) is a transition metal required in mammalian
cells as a cofactor and structural component of a wide variety of
cellular proteins, as well as a signaling molecule. Consequently,
intracellular Zn2 bioavailability is essential for various cellular
components and signaling pathways necessary for the survival
and growth of mammalian cells. To ensure an adequate control
of intracellular Zn2 levels, cells possess specific transport pro-
teins on both plasma and organellar membranes as well as spe-
cialized storage and carrier proteins in the cytoplasm (1). Zn2
transporter proteins are grouped into two solute carrier fami-
lies, SLC39 and SLC30, that differ in terms of the direction of
metal ion transport. SLC39 transporters accumulate Zn2 into
the cytoplasm (i.e. import from the extracellular medium and
export from intracellular organelles), whereas SLC30 trans-
porters mobilize Zn2 out of the cytoplasm in the opposite
direction (2). The SLC39 family, also known as ZIP (Zrt-, Irt-
like proteins), is constituted by 14 differentmembers, which are
subdivided into subfamilies I, II, LIV-1, and gufA, according to
their sequence similarities (3). To date, there is no direct struc-
tural information available for any full-length mammalian ZIP
transporter. However, all the ZIP members are predicted to
have eight transmembrane domains, with theirN andC termini
facing the extracellular space (1, 4). Interestingly, recent com-
putational studies using co-evolution contact predictions and
Rosetta ab initio structure prediction generated the firstmolec-
ular model for a mammalian ZIP transporter (5). This model of
human ZIP4, a member of the subfamily LIV-1, exhibits eight
transmembrane helices (TMH),6 in which TMHs 2, 4, 5, and 7
form a helical bundle containing the putative metal-coordina-
tion site. Alanine replacement of the histidine and aspartic acid
residues present in the proposed metal-coordination site
altered the Zn2 transport kinetics, validating this structural
model (5). The described metal-coordination site resembles
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that of the crystal structure of the SLC30 family homolog YiiP
(6) (i.e. Escherichia coliZn2/H antiporter), suggesting a com-
mon structural element for the different Zn2 transporters.
Another interesting aspect revealed by these studies is that the
predicted contacts used as a basis to build themodel could only
be observed when ZIP4 was modeled as a dimer in which the
TMHs form the dimer interface (1, 5). This finding is supported
by previous evidence of homodimerization of other ZIP trans-
porters, such as ZIP2, ZIP7, and ZIP13, or the heteromer of
ZIP6 and ZIP10 (1). Although not included in the computa-
tional model, ZIP transporters are predicted to possess a large
cytoplasmic loop between TMHs 3 and 4, which contains a
variety of zinc-coordination sites likely functioning as a regula-
tory region that senses and responds to changes in intracellular
Zn2 concentration (1). Recently, the first experimental evi-
dence of the overall structure emerged through the crystalliza-
tion of a prokaryotic ZIP homolog, bbZIP, showing remarkable
overall agreement with the previously described theoretical
model (7). Based on the X-ray structure, a structural model of
the human ZIP4 protein was derived, and several structural
elements of the protein, such as the substrate-binding site, have
been identified (7).
In terms of the functional properties of the SLC39/ZIP fam-
ily, members of this family transport a wide variety of divalent
metals in addition to Zn2, including iron (Fe2), manganese
(Mn2), copper (Cu2), and cadmium (Cd2) (1). Even though
the transport mechanism of ZIPs is not yet fully understood, it
has been reported that the transport process is not dependent
on ATP hydrolysis (8, 9) and, for some of the ZIP transporters
such as ZIP2, ZIP8, and ZIP14, a Zn2/HCO3 symport mech-
anism has been proposed (8, 10, 11). In contrast, studies con-
ducted with a bacterial ZIP transporter suggested that this pro-
teinmight function as an ion-selective channel inwhichZn2 is
incorporated into the cytoplasm via an electro-diffusionmech-
anism (12).
SLC39A2, also known as ZIP2, belongs to the ZIP subfamily
II, and it was cloned and functionally characterized for the first
time byGaither and Eide in the year 2000 (8). In thatwork it was
described that ZIP2-overexpressing K562 cells (human immor-
talized myelogenous leukemia cell line) accumulate Zn2 in a
time-, temperature-, and concentration-dependent manner,
that the transport process was independent of ATP hydrolysis
as well as Na and K gradients, and was stimulated in the
presence of extracellular HCO3 but inhibited by lowering the
extracellular pH. Altogether, these findings indicated that ZIP2
behaved as a Zn2/HCO3 symporter (8). In contrast, prior
work conducted in our laboratory suggested that ZIP2 activity
is stimulated rather than inhibited by the presence of H (13).
In a more recent study, we showed that ZIP2-mediated trans-
port in both microinjected Xenopus laevis oocytes and tran-
siently transfectedHEK293 cells is independent of bothHCO3-
and H-driving forces, but modulated by extracellular pH and
voltage (14). However, structural details of how H affects
transport activity are still missing and remain to be described.
Originally, ZIP2 expression was detected in uterus and pros-
tate (8), in the latter also at the protein level (15). In prostate
cancer cells, ZIP2 is down-regulated to decreased zinc levels,
thereby restoring m-aconitase 2 activity and promoting ATP
production via the tricarboxylic acid cycle (15–20). Similarly,
low zinc levels and increased ZIP2 expression have also been
linked to pulmonary inflammatory diseases (21, 22). ZIP2 also
seems to play a role upon zinc depletion. Cao et al. (23) found
that zinc depletion in peripheral blood mononuclear cells and
the THP-1 monocytic cell line triggered up-regulation of ZIP2
with the concomitant down-regulation of zinc-binding metal-
lothioneins. Later studies also found ZIP2 expression inmacro-
phages, where it was themost responsive gene upon zinc deple-
tion (24). Recently, in healthy human skin samples, Inoue et al.
(25) discovered that ZIP2 is up-regulated upon the induction of
differentiation in cultured keratinocytes. Interestingly, ZIP2
knockdown inhibited the differentiation of keratinocytes and
consequently the formation of a three-dimensional cultured
epidermis. Studies with ZIP2–KOmice did not reveal any spe-
cific phenotype. However, these mice were more susceptible to
abnormal embryonic development because of zinc deficiency
during pregnancy (26). Taken together, these physiological
roles warrant amore detailed investigation of the transport and
ion-coupling mechanism of subfamily II ZIP transporters, of
which ZIP2 is the most well-characterized member.
In this work, taking advantage of the first available human
ZIP4 model (5), we developed a homology-based model for
human ZIP2 and proposed residues that might play a role in
both Zn2-coordination and H-mediated modulation of the
transport process. Site-directed mutagenesis of the proposed
amino acid residues followed by detailed functional character-
ization of mutants validated the proposed model and provided
the first structural details of the Zn2-coordination site andH
modulation of the transport process mediated by human ZIP2.
In addition, through comparison of our model with another
model built based on the bbZIP structure, we propose a trans-
port mechanism for H-sensitive transport of divalent metal
ions and functional hot spots within the protein structure.
Results
Model of human ZIP2 based on the previously published
human ZIP4model
For starting our structure–function studies, we have chosen
to construct a homology-based model of human ZIP2 based on
a previously published structure of human ZIP4 that was
derived from the analysis of co-evolving residue pairs in the
protein family (5). The objective of our work was to identify
residues within the transmembrane region that could poten-
tially have functional roles in transport. Based on our structural
model, we could identify a set of residues that possibly form the
substrate-binding site (His-175, His-202, and Glu-179; Fig. 1A)
based on ZIP4 data (5). These residues seem to be conserved in
the human SLC39 family (Fig. 1B). Because Zn2 usually binds
in a tetrahedral coordination geometry, we were also interested
to test whether two nearby residues, Phe-269 and Ser-176, con-
tribute to Zn2 binding during the transport process. A series
of titratable residues was also identified on TMH 2 (His-63,
Glu-67, Glu-70, and Glu-71; Fig. 1A), which we suspected
might play a role in substrate recruitment to the binding site, or
pH sensitivity of transport previously described by our group
(14). Additionally, two acidic residues (Glu-106 and Glu-120)
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were identified, which extend toward the membrane bilayer
(Fig. 1A). Their unusual orientation prompted us to add them
to the list of residues whose role in transport function we
wanted to test.
We next sought to determine the impact of the selected res-
idues on transport activity and pH-dependence of humanZIP2.
To this end, selected amino acid residues were substituted by
either alanine or, in the case of acidic residues, the protonation-
mimicking side-chain glutamine. For His-202, the glutamate
substitution was also probed with the anticipation that it might
alter transport selectivity, as glutamate is the corresponding
residue in human ZIP8 and ZIP14 (Fig. 1B), which have been
shown to transport Fe2 in addition toZn2 (27, 28). In the case
of Phe-269, which we anticipated might interact with the diva-
lent metal ion substrate via cation– interactions, the leucine
substitution was also tested, because it is a similarly-sized
hydrophobic side chain that lacks the aromatic ring and thus is
unable to form cation– interactions.
Plasmamembrane expression and functional activity of ZIP2
single-point variants
The effects of the introduced single-point mutations on the
basal plasma membrane expression of human ZIP2 were
assessed by immunoblotting membrane protein samples iso-
lated by surface biotinylation.All the generatedmutant variants
were found to be expressed in the plasma membranes of tran-
siently transfected HEK293 cells; however, some of them
showed lower expression levels thanWTZIP2 (Fig. 2,A and E).
Consequently, in all subsequent functional experiments the
obtained results for each of the testedmutantswere normalized
to their respective average plasma membrane surface expres-
sion levels (Fig. 2, D and H).
Next, the functional activities of the generated ZIP2 variants
were studied using our fluorescence-based Cd2-flux assay
(Fig. 3) (13, 14). All the mutants generated to identify possible
H-interaction sites showed altered transport activity (Fig. 3A).
Remarkably, mutants H63A and E67A and to a lesser extent
E106A showed a decrease of 60, 35, and 30% in Cd2 trans-
port, respectively, whereas mutants E70A and E106Q showed
an increase of 65 and 35% in Cd2 transport, respectively.
These findings are compatible with a role of these amino acid
residues in modulating the effect of extracellular H on the
ZIP2 transport.
With respect to amino acid residues proposed as part of
the substrate-binding site (Fig. 3B), our results indicate that
amino acids His-175, Glu-179, and His-202 might indeed be
relevant for substrate binding, but a role for Phe-269 and
especially for Ser-176 seems less likely. Mutations of His-175
and His-202 to alanine were completely inactive, but the
E179A variant showed a highly significant reduction of Cd2
transport (60%). Interestingly, the mutation to glutamine
at position 79 completely blocked the transport activity,
highlighting the restrictive character of the physicochemical
properties required at this position to allow substrate trans-
port. In contrast, conservative mutation of amino acid His-
202 to glutamate rescued the activity of ZIP2 by 60% if
compared with the alanine variant. Mutation to alanine at
Ser-176 did not alter transport activity, whereas in the case
of F269A variant, the transport activity was reduced by
40%. Replacement of Phe-269 by leucine also did not alter
transport activity, indicating that the presence of an aro-
matic residue at that position is not essential for the trans-
port process.
Figure 1. Structurally and functionally relevant amino acid residues in human ZIP2 (SLC39A2). A, model of human ZIP2 based on the previously
publishedmodel of human ZIP4 (5). Transmembrane helices are numbered 1–8 and colored according to internal structural symmetry. Selected residues that
can directly participate in substrate binding are highlighted based on the ZIP4model. In addition, a cluster of titratable residues on TMH 2 lining the putative
pathway to the substrate-binding site is highlighted, which might interact with protons. Two acidic residues (Glu-106 and Glu-120) curiously facing the
membrane interface are also shown. B, conservation of putative Zn2-binding residues on TMHs 4 and 5 are shown in the human SLC39/ZIP family and
prokaryotic homolog bbZIP. The complete alignment is available in Fig. S1.
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Substrate transport kinetics
To verify whether the introduced mutations have a direct
effect on the binding of the substrate by human ZIP2, kinetic
studies of the Cd2 transport (at extracellular pH 6.5) were
conducted. ZIP2 showed an apparent affinity for Cd2 of1.46
M (Fig. 4A, upper panel), whereas the response of the mock-
transfected cells to increasing extracellular [Cd2] lacked
Michaelis-Menten kinetics (Fig. 4A, lower panel). As
expected, when compared with ZIP2, the transport kinetics
of the mutants generated for the residues proposed as part of
the H-interacting sites (Fig. 4B) showed differences in the
Vmax values but not in the affinity for Cd2, showing Km
values in a similar range to that of WT ZIP2 (Fig. 4C). Con-
cerning the mutants of positions predicted as part of the
substrate-binding site (Fig. 4D), mutants H175A, E179Q,
and H202A were not active within the range of tested extra-
cellular [Cd2], supporting the relevance of this cluster of
residues for the substrate binding. In contrast, mutants
H202E, F269A, and F269L had transport kinetics very similar
to those observed for WT ZIP2 (Fig. 4E). Interestingly, while
still active, the E179A variant displayed a lower apparent
affinity for Cd2 of 6.78 M, indicating that the titratable
side chain of Glu-179 is directly mediating the binding of the
substrate to ZIP2.
Figure 2. Plasmamembrane expressionof generatedZIP2mutant proteins. Plasmamembranes of transiently transfectedHEK293 cells were labeledwith
sulfo-NHS-LC-biotin and isolated on streptavidin-agarose beads. Representative blots showing the plasmamembrane expression of the single-pointmutants
of the residues present in the proposed H-interaction (A) and substrate-binding (E) sites. Assessment of the purity of the isolated plasmamembranes by the
determination of the expression of theNa/H exchanger (NHE1) and the absence of actin (B and F) is shown. Determination of biotin labeling of each sample
as loading control is shown (C and G). Relative expression of the indicated proteins was established as the OD of the corresponding bands. Values from three
to five independent experiments were normalized to their respective loading controls and expressed as percentage of the expression of WT ZIP2 (D and H).
Structural basis of transport in SLC39A2
J. Biol. Chem. (2019) 294(20) 8046–8063 8049
 at U
niversitaetsbibliothek Bern on July 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
pH-dependence
To evaluate the effect of extracellular pH on the transport
activity of human ZIP2 variants, kinetic studies with a stable
substrate concentration (10MCd2) but variable extracellular
pH values (6.5–8.2) were conducted. WT ZIP2 showed an
apparent affinity for H of 50 nM, corresponding to a pH of
7.3 (Fig. 5A, upper panel). Mock-transfected cells did not
exhibit significant Cd2 transport at any of the tested extracel-
lular pH values (Fig. 5A, lower panel). Of themutants generated
to determine possible H-interacting sites (Fig. 5B), variant
H63A showed a complete loss of pH-dependence,whereas vari-
ants of residues Glu-67 and Glu-106 showed a higher apparent
affinity for H than WT ZIP2, indicating that these residues,
together withHis-63, are critical for pH-mediated regulation of
transport
by ZIP2 (Fig. 5C). Interestingly, the apparent H affinity of
mutants at residues Glu-70, Glu-71, andGlu-120were in a sim-
ilar range to that calculated for WT ZIP2; however, Vmax of
these mutants was considerably increased, especially when res-
idues were mutated to alanine (Fig. 5C). With respect to the
mutants at positions predicted to be part of the substrate-bind-
ing site (Fig. 5D), as expected, no significant effect on the appar-
ent H affinity was observed (Fig. 5E). However, ZIP2 mutants
of residue Phe-269 displayed a higher H affinity than WT
ZIP2 (Fig. 5E), suggesting a possible role of this residue in the
pH-dependence of the transport process.
Substrate selectivity
Next, we wanted to elucidate the role of the residues pro-
posed as part of the substrate-binding site (Ser-176, Glu-179,
His-202, and Phe-269) in humanZIP2 substrate selectivity (Fig.
6). To this end, Cd2 transport mediated by the functionally
active ZIP2 mutants (S176A, E179A, H202E, F269A, and
F269L) wasmeasured in the presence of high extracellular con-
centrations (50 M) of different divalent metals (Zn2, Cu2,
Co2, Mn2, and Ba2). Note that none of these metals
induced significant changes on the fluorescent baseline in the
absence of Cd2 (data not shown). As described previously by
our group for human ZIP2 (14), Mn2 and Ba2 were not able
to compete with Cd2 under the tested conditions, whereas the
affinity for the other divalent metals decreased as follows: Zn2
 Cu2  Co2. Mutation to alanine at Ser-176 did not alter
the substrate selectivity of ZIP2, which, together with the lack
of effect of this mutation on the apparent affinity for Cd2 (Fig.
4E), indicates that this residue is not relevant for the substrate
binding. Variant E179A showed the same substrate selectivity
as WT but with smaller differences between substrates, which,
together with its decreased affinity for Cd2 (Fig. 4E), indicates
an overall reduction of the transport capacity rather than
altered substrate selectivity for this variant. Interestingly, vari-
ants of residues His-202 and Phe-269 exhibited a broader sub-
strate selectivity, given that Mn2 was able to significantly
inhibit Cd2 transport by these variants. Moreover, although
the inhibition of Cd2 transport by Mn2 was more pro-
nounced for the Phe-269 variants, H202E-mediated Cd2
transport was also inhibited by Ba2. This might indicate that
the size of the side chain at these positions limits the access to
the binding site for larger substrates, as in both cases the appar-
ent affinity for Cd2 remained unaltered (Fig. 4E). Because the
conservative variant H202E is present in other members of the
ZIP family (Fig. 1B), this might explain why this mutation did
not alter the apparent affinity for Cd2 but modified the sub-
strate selectivity. In particular, the H202E variant is present in
the ZIP8 and ZIP14 transporters, which have been widely
reported to transport iron (28). To test whether Fe2 can be
transported by the binding site–related human ZIP2 variants
(S176A, E179A, H202E, F269A, and F269L), radiolabeled 55Fe-
uptake experiments were conducted. Given thatWTZIP2 does
not transport Fe2, as a positive control, the human divalent
metal transporter SLC11A2/DMT1 was included in the exper-
imental set (Fig. 6B). When compared with DMT1-mediated
Fe2 uptake, no significant uptake was observed for any of the
ZIP2 variants tested.However, among theZIP2mutants, F269L
seemed to be able to transport Fe2, further supporting the idea
that this residue affects the substrate selectivity of human ZIP2,
even though it is not directly part of the binding site.
Voltage-dependence
As reported previously (14), humanZIP2 transport activity is
inhibited in the presence of high extracellular K as a conse-
Figure 3. Functional activity of generated ZIP2mutant proteins.Cd2 transport by transiently transfectedHEK293 cells expressing the indicated proteins,
including the single-pointmutants of the residues present on the putative H-interaction (A) and substrate-binding sites (B). Transport activitywasmonitored
as the changeof the fluorescence intensity of theCalcium5dyeuponperfusionof Cd2 (10M) during10min (extracellular pH6.5). The activitywasquantified
as theAUCandexpressedaspercentageof the activity determined forWTZIP2. For eachof the indicatedproteins, results from three independent experiments
(n 32–68) were pooled together and represented as themean S.D. Statistical differences were assessed as described previously (Cd2 uptake by ZIP2WT
versus each mutant); ns, p 0.05; **, p 0.01; ***, p 0.001.
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quence of the depolarization of the membrane potential due to
the K flux into the cell. Accordingly, we propose that the
voltage-dependence described for human ZIP2 could be the
consequence of conformational changes due to electrostatic
forces exerted by the membrane potential on charged protein
residues located within the binding cavity. In this regard,
Figure 4. Cadmium transport kinetics of generated ZIP2 mutant proteins. A, representative experiments showing the changes of fluorescence intensity
recordedwhen transiently transfected HEK293 cells expressing ZIP2WT (upper panel) and empty vector (lower panel) were perfusedwith increasing [Cd2] (0.
1–10M). Average transport activity by the single-pointmutants of the residues present on the proposed H-interaction (B) and substrate-binding (D) sites in
response to increasing [Cd2] at extracellularpH6.5 (10min incubation) is shown. Transport activitywasquantifiedas theAUC. For eachof the studiedproteins,
the obtained AUC values were normalized to their respective average plasma membrane expression levels (Fig. 2) and expressed as percentage of the WT
activity in response to Cd2 (10 M). Data from three independent experiments (n  9–20) were pooled together and represented as mean  S.D. The
Michaelis-Menten equationwas fit to the represented data (solid line). Summary tables of the kinetic parameters calculated for each of the generatedmutants
related to the putative H-interaction (C) or substrate-binding (E) sites are shown.
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Figure 5. pH-dependence of Cd2 transport by generated ZIP2 mutant proteins. A, representative experiments showing the changes of fluorescence
intensity recordedwhen transiently transfectedHEK293cells expressingZIP2WT (upper panel) andemptyvector (lower panel)wereperfusedwithCd2 (10M)
at different extracellular [H] (pH 6.5–8.2). Average transport activity by the single-point mutants of the residues present on the proposed H-interaction (B)
and substrate-binding (D) sites in response to Cd2 (10M) perfusion in the presence of increasing [H] (10min) is shown. Transport activity was quantified as
the AUC. For each of the studied proteins, the obtained AUC were normalized to their respective average plasma membrane expression levels (Fig. 2) and
expressedaspercentageof theWTactivity in response toCd2 transport atpH6.5.Data fromthree independent experiments (n8–36)werepooled together
and represented as mean  S.D. The Michaelis-Menten equation was fit to the represented data (solid line). Summary tables of the kinetic parameters
calculated for each of the generated mutants related to the putative H-interaction (C) or substrate-binding (E) sites are shown.
Structural basis of transport in SLC39A2
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altered electrostatic forces upon membrane depolarization by
K influx could result in structural changes that inhibit the
transport process. To test whether this inhibition is related to
the residues proposed to be H-interaction sites, the uptake of
Cd2 by the human ZIP2 variants showing altered pH-depen-
dence (H63A, E67A, E67Q, E106A, E106Q, F269A, and F269L)
(Fig. 5E) was determined in the absence and presence of high
extracellularK (Fig. 7). As reported previously, in the presence
of high extracellular K, the Cd2 transport mediated by WT
ZIP2 is inhibited by 25%. Interestingly, a similar effect was
observed for mutants E106A, E106Q, and F269A but not for
mutants H63A, E67A, E67Q, and F269L. Glu-106 is located in
an extracellular loop, whereas Glu-67 and His-63 are located
within the binding cavity, in line with our hypothesis that the
inhibitory effect induced by depolarization only affects charged
residues within the binding cavity. Unexpectedly, at the Phe-
269 position, which is located near the binding site, Cd2 trans-
port in the presence of K upon alanine substitution resembles
that ofWT ZIP2, whereas when Phe-269 is mutated to leucine,
the inhibitory effect is lost.
Structural model of human ZIP2 based on the prokaryotic
bbZIP X-ray structure
During our work, the structure of a transporter (bbZIP) ho-
mologous to the SLC39 family has been solved from Bordetella
bronchiseptica, at 2.4 Å resolution (7). This protein was crystal-
lized in an inward-open conformation, with a peculiar binu-
clear metal-binding site, featuring two divalent metal ions.
Zhang et al. (7) also generated a homology-based model of
human ZIP4 (7). However, because many of the residues
described by them as part of the substrate-binding site are not
conserved in human ZIP2, we decided to generate a structural
model of human ZIP4 based on the prokaryotic bbZIP struc-
ture. This “new”model of ZIP2 (Fig. 8A) is in overall agreement
with our previousmodel based onAntala et al. (5) (“old”model,
Fig. 1A). The residues we have identified as part of the sub-
strate-binding site cluster around the location where the cen-
trally bound Zn2 ion in the bbZIP structure was observed (Fig.
8B). Interestingly, the location of the second divalent metal ion
observed in the bbZIP structure is occupied by the amino head-
group of the Lys-203 residue in human ZIP4 (Fig. 8B). We also
observed that due to a rotation of TMH3 in the “new” structure
compared with the “old” structure, the Glu-120 side chain no
longer faces the membrane bilayer interface. In addition, the
Glu-106 side chain, together with Glu-101 and Glu-73, faces an
orientation that could constitute a dimer interface, if the pro-
tein was modeled as a dimer based on the dimeric model of
human ZIP4 (Fig. 8C) by Antala et al. (5). These three acidic
residues are partially conserved in subfamily II but absent from
other members of the SLC39 family (Fig. 8D).
Because the hypothesis of a binuclear metal-binding site
emerged during our work, we decided to generate additional
mutants based on our new model, which we feel is more
reliable due to the support of crystallographic data, to inves-
tigate the nature of the binding site. In particular, we chose to
Figure 6. Apparent substrate selectivity of substrate-binding site–related ZIP2 mutant proteins. A, average Cd2 transport by transiently transfected
HEK293 cells expressing the indicated proteins. Cd2 (1 M) uptake was recorded in the presence of an excess (50 M) of the indicated divalent metals at
extracellular pH 6.5 during 10min. Transport activity was quantified as the AUC and expressed as percentage of the transport in response to Cd2 (1M). Data
from two to three independent experiments (n 12–24) were pooled together and represented as the mean S.D. B, representative experiment showing
radiolabeled 55Fe uptake by transiently transfected HEK293 cells expressing the indicated proteins. 55Fe uptake was determined in the presence of 1M Fe2
at extracellular pH 5.5 after 15min of incubation. C, average Fe2 transport by transiently transfected HEK293 cells expressing the indicated proteins. For each
of the indicated proteins, the 55Fe-uptake values were normalized to their respective average plasma membrane expression levels (Fig. 2) and expressed as
percentage of the Fe2 transport by WT ZIP2. Data from two independent experiments (n 63–68) were pooled together and represented as mean S.D.
Statistical differenceswere assessed as described previously (Cd2 uptake in the absence versus the presence of each divalentmetal); ns, p 0.05; **, p 0.01;
***, p 0.001.
Figure 7. Voltage-dependence of H-interaction site–related ZIP2 mutant proteins. Average Cd2 transport by transiently transfected HEK293 cells
expressing the indicated proteins in the absence (light gray dots) and presence (dark gray dots) of high extracellular [K] (140 mM). Cd2 (10 M) uptake was
recorded at extracellular pH 6.5 during 10 min. Transport activity was quantified as the AUC. For each of the indicated proteins, the obtained AUC were
normalized to their respective average plasma membrane expression levels (Fig. 2) and expressed as percentage of the transport recorded for ZIP2 WT in
standard uptake buffer (KB buffer), pH 6.5. Data from four independent experiments (n  9–15) were pooled together and represented as mean  S.D.
Statistical differences were assessed as described previously (Cd2 uptake in the absence versus the presence of 140mM K); ns, p 0.05; *, p 0.05; ***, p
0.001.
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mutate residues Lys-203 and Ser-235 to test for the presence of
the second divalent metal-binding site, as well as Glu-276,
which resides in the proximity of the proposed binding site in
the new model, and could form the fourth substrate-binding
bond, thereby forming a tetrahedral coordination geometry
(Fig. 8B). For these three residues, alanine substitution as well
as conservative (K203R) and uncharged polar (K203Q and
E276Q) mutations were generated.
Plasmamembrane expression and functional activity of
additional ZIP2 single-point variants
Plasma membrane expression of the generated human ZIP4
mutants was determined by immunoblotting of proteins iso-
lated by surface biotinylation. All the mutants were expressed
in the plasma membrane of the transfected cells to a level sim-
7 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure8.ModelofhumanZIP2basedonthebbZIPX-raystructure.A,overall structureofhumanZIP4basedon thebbZIPX-ray structure (7); theorientation
in the bilayer is based on the Orientations of Proteins in Membranes (https://opm.phar.umich.edu/)7 (47) prediction for bbZIP. TMHs are numbered 1–8 and
colored according to the internal symmetry (TMH4 is behind andnot visible from this angle). Residues tested in thiswork and shown tobe relevant for function
are highlighted. B, zoom-in on the anticipated substrate-binding site. Position of the bound Zn2 substrate, as anticipated based on the bbZIP X-ray structure,
is shown as a green sphere. The location of the second bound divalent ion in the bimetal-binding site of bbZIP is shown as a light orange sphere. In human ZIP4,
the amino group of the Lys-203 side chain occupies this position. In addition, the residue Glu-276 might also participate in substrate binding, as described in
the text. C, view of the ZIP2 protein from the extracellular side showing two distinct groups of charged/titratable residues, marked by dashed and solid circles.
A putative dimeric arrangement of the proteins is shown (symmetric subunit in gray) based on the previously described human ZIP4model. The location of an
additional bound Zn2 ion observed in the bbZIP X-ray structure is shown as a green sphere close to Glu-106.D, conservation of residues 63–73, 101–120, and
262–276 in the human SLC39/ZIP family and the prokaryotic homolog bbZIP. The complete alignment is available in Fig. S1.
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ilar to WT ZIP2 (Fig. 9A). Subsequent experiments were nor-
malized to the average plasmamembrane expression of each of
the mutant proteins (Fig. 9D).
Functional activity of the generated mutants was assessed by
our fluorescence-basedCd2-flux assay (Fig. 9E) (13, 14).Mutants
ofLys-203showedahighly significant reductionontheir transport
capacity. Cd2 transport by mutants K203Q and K203R was
reduced by78 and 72%, respectively, whereas K203Qwas com-
pletely inactive. This indicates that Lys-203 plays a significant role
in the human ZIP2-mediated transport process. Regarding Ser-
235, mutation to alanine reduced the transport of Cd2 by36%,
suggesting that this residue might also have some functional rele-
vance. Remarkably, mutation to alanine at Glu-276 abolished
Cd2 transport completely, whereas mutation to glutamine
retained the activity ofWTZIP2 almost completely. This is in line
withourhypothesis ofGlu-276beingpart of the substrate-binding
site. These resultsmight also indicate that protonation ofGlu-276
is necessary to achieve transport of the substrate, as the E276Q
variant behaved like WT ZIP2 and the absence of a side chain at
E276A resulted in loss of transport activity.
Detailed functional characterization of the additional ZIP2
single-point variants
To further evaluate the effect of the mutations on human
ZIP2 function, different aspects of the transport mechanism
were studied.
First, the substrate transport kinetics of the generated mutants
were evaluated (Fig. 10). In line with our previous observations,
mutations at Lys-203 and Ser-235 exhibited reduced Vmax values
comparedwithWTZIP2.However, the apparent affinity forCd2
remained unaltered. This indicates that none of these residues are
directly involved in the metal-binding process, hence disproving
the hypothesis of a second substrate-binding site. In contrast,
mutations at Glu-276 exhibited reduced affinity for Cd2. Calcu-
lated Km values for E276A and E276Q were 7- and 3-fold higher,
respectively, than those of WT ZIP. These findings confirm our
hypothesis ofGlu-276being themissingmetal-coordinatingpoint
for the proposed binding site. Accordingly, we decided to assess
the impactof thismutationonthesubstrate selectivityof the trans-
porter (Fig. 10C). Substrate selectivity remained similar to WT;
however, the overall Cd2 transport activity in the presence of
Zn2, Cu2, and Co2 was 2, 2, and 1.5-fold higher than
WT, respectively. This result, together with the significant inhibi-
tion of Cd2 transport by Mn2 by 20%, further supports the
role of Glu-276 as part of the substrate-binding site. The overall
decreased inhibition of Cd2 transport by the other metals might
reflect the lower substrate affinity of this variant, although its
capacity to transportMn2 in contrast toWTZIP2, even if mini-
mal, indicates that this residuemight also be relevant to the selec-
tivity of the transporter.
Next, the effect of the extracellular pH on the transport
mediated by the generated mutants was assessed (Fig. 11).
Interestingly, except for Ser-235, all the mutants showed
altered apparent affinity for H. Nevertheless, although for
mutants K203A and E276Q the apparent affinity for H was
reduced by 2.5- and 4-fold, respectively, and for mutant
K203R it was increased by 3-fold. These results suggest that
even though the Lys-203 is not directly involved in metal bind-
ing, its protonation state seems to be highly relevant to the
electrostatic balance of the substrate-binding cavity. Likewise,
Glu-276 is also involved in the pH sensitivity of the transport
process, as the mutation to a “protonated-like” form (E276Q)
substantially altered the pH-dependence of the transport pro-
cess. To further study the contribution of these residues to the
electrostatic balance of the binding cavity, the voltage-depen-
Figure 9. Plasma membrane expression and functional activity of generated ZIP2 mutant proteins. Plasma membranes of transiently transfected
HEK293 cells were labeled with sulfo-NHS-LC-biotin and isolated on streptavidin-agarose beads. A, representative blot showing the plasma membrane
expressionof the indicated single-pointmutantproteins.B, assessmentof thepurity of the isolatedplasmamembranesby thedeterminationof the expression
of the Na/H exchanger (NHE1) and the absence of actin. C, determination of biotin labeling of each sample as loading control. D, relative expression of the
indicated proteins was established as the OD of the corresponding bands. Values from three to five independent experiments were normalized to their
respective loading controls and expressed as percentageof the expression ofWTZIP2. E,Cd2 transport by transiently transfectedHEK293 cells expressing the
indicated proteins. Transport activity was monitored as the change of the fluorescence intensity of the Calcium 5 dye upon perfusion of Cd2 (10 M) during
10 min (extracellular pH 6.5). The activity was quantified as the AUC and expressed as percentage of the activity determined for WT ZIP2. For each of the
indicated proteins, results from at least three independent experiments (n  32–44) were pooled together and represented as the mean  S.D. Statistical
differences were assessed as described previously (Cd2 uptake by ZIP2 WT versus each mutant); *, p 0.05; ***, p 0.001.
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dence of the mutants were studied (Fig. 11C). Interestingly,
mutations at Lys-203 abolished the effect of K on Cd2 trans-
port, confirming the contribution of this residue to the electro-
static balance and overall voltage-dependence of the trans-
porter. In contrast, the E276Q mutant was still slightly
inhibited by K, which indicates that its contribution to this
aspect of the transport process is limited.
pKa calculations
Becausewe have observed a cluster of charged residues lining
TMH 2, some of which also seem to determine the pH sensitiv-
ity of transport and apparent binding affinity toward protons
(His-63 and Glu-67), we suspected that perturbation of these
side chains by mutation would affect the local electrostatic
environment, and thus the binding affinity for protons. There-
fore, we performed calculations to estimate the pKa value of
titratable protein side chains in ZIP2, also taking into account
the membrane environment. First, we tested the effect of the
presence of the Zn2 substrate in the proposed binding site
(Fig. 8B), which caused a marked shift in side chain pKa values
of directly coordinating residues, i.e. Glu-179, His-175, and
His-202 (Table 1). A marked shift was also observed for Glu-
276 and Lys-203. Interestingly, the pKa of Lys-203 due to the
presence of the substrate dropped to physiological values
(6.69). A slight shift due to the presence of the substratewas also
observed for residues in the charged cluster near His-63
Figure 10. Cadmium transport kinetics and substrate selectivity of generated ZIP2 mutant proteins. A, average transport activity by the single-point
mutants in response to increasing [Cd2] (0. 1–10M) at extracellular pH 6.5 (10min incubation). Transport activity was quantified as the AUC. For each of the
studied proteins, the obtained AUC values were normalized to their respective average plasma membrane expression levels (Fig. 9) and expressed as
percentage of the WT activity in response to Cd2 (10 M). Data from three independent experiments (n 12–20) were pooled together and represented as
mean S.D. The Michaelis-Menten equation was fit to the represented data (solid line). B, summary table of the kinetic parameters calculated for each of the
generatedmutants. C, average Cd2 transport by transiently transfected HEK293 cells expressing the indicated proteins. Cd2 (1M) uptake was recorded in
the presence of an excess (50 M) of the indicated divalent metals at extracellular pH 6.5 during 10 min. Transport activity was quantified as the AUC and
expressed as percentage of the transport in response to Cd2 (1M). Data from two to three independent experiments (n 26–34)were pooled together and
represented as mean S.D. Statistical differences were assessed as described previously (Cd2 uptake in the absence versus the presence of each divalent
metal); ns, p 0.05; **, p 0.01; ***, p 0.001.
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(including His-63, Glu-67, Glu-71, and Glu-262). As a second
step, we repeated the calculations with mutant variants of our
ZIP2model. The introduction of the H63A substitution, which
completely abrogated pH-dependence of transport in our
experiments, only affected the pKa ofGlu-262with a downward
shift of more than 0.1 unit (Table 1 and Table S1). Interestingly,
introduction of either K203A or K203Qmutation caused a dra-
matic shift of the side-chain pKa of Glu-179, raising it closer to
physiological values (7.6–8.0). In the K203R variant, theArg-
203 side chain was predicted to have a pKa 2.12 units higher
than Lys-203 in WT, whereas the pKa values of all other resi-
dues were shifted by less than 1 unit (Table 1 and Table S1).
Discussion
Our combined in silico and in vitro efforts successfully iden-
tified key residues that are responsible for substrate binding and
pH sensitivity of human ZIP2. In addition, based on structural
comparison of our old and new models of ZIP2, we present a
hypothetical mechanism of metal ion transport.
Substrate-binding site
Based on our results, it seems evident that Glu-179, His-175,
His-202, and Glu-276 directly bind the divalent metal ion sub-
strate, which is in line with previous studies on SLC39 proteins
(5), as well as our modeling efforts (Figs. 1A and 8, A and B).
Importantly, ourmodel of ZIP2 based on the prokaryotic bbZIP
structure suggests that the binding site of human ZIP2 is only
able to bind a single divalent ion. Indeed, our experiments sug-
gest that removal of the nonconserved side chains forming the
second binding site in bbZIP (Lys-203, Ser-176, and Ser-235)
does not affect the binding affinity of the substrate. Instead, we
hypothesize that the presence of a positive charge in the formof
a proton near the analogous residues of the second metal ion–
binding site in bbZIP is essential for transport in human ZIP2.
In the WT protein, this charge is represented by the proton
carried by the side chain of Lys-203, which also coordinates the
side chain of Glu-179 to an optimal substrate-binding orienta-
tion. In the K203A variant, the proton might bind to the Glu-
179 side chain instead. The predicted pKa of Glu-179 in the
K203A mutant (7.98, Table 1) is lower than that of Lys-203 in
the WT protein (10.31), which is in line with the observed
downward shift in proton-binding affinity of K203A, compared
with WT. In case of the K203R variant, the estimated pKa of
Arg-203 is higher thanWT (12.43), corresponding to the higher
observed proton-binding affinity of this variant. However, it is
likely that the larger Arg residue fails to efficiently coordinate
the Glu-179 residue in a competent substrate-binding orienta-
tion, or it causes other structural distortions that severely
impact the function of the protein. In case of theK203Qvariant,
which proved to be nonfunctional in our experiments, the
introduced Gln residue might form H-bond interactions with
the nearby Glu-179 side chain, thus preventing proton binding
and rendering the transporter nonfunctional. The single diva-
lent binding site seems to be a unique property of subfamily II of
the SLC39 family (SLC39A1–3) based on sequence conserva-
Figure 11. pH-dependenceof Cd2 transport bygeneratedZIP2mutant proteins.A, average transport activity by the single-pointmutants in response to
Cd2 (10M) perfusion in the presence of increasing [H] (pH 6.5–8.2) (10min). Transport activity was quantified as the AUC. For each of the studied proteins,
the obtained AUCwere normalized to their respective average plasmamembrane expression levels (Fig. 9) and expressed as percentage of theWT activity in
response to Cd2 transport at pH 6.5. Data from three independent experiments (n  8–28) were pooled together and represented as mean  S.D. The
Michaelis-Menten equationwas fit to the representeddata (solid line). B, summary tableof the kinetic parameters calculated for eachof the generatedmutants.
C, average Cd2 transport by transiently transfected HEK293 cells expressing the indicated proteins in the absence (light gray dots) and presence (dark gray
dots) of high extracellular [K] (140mM). Cd2 (10M) uptakewas recorded at extracellular pH 6.5 during 10min. Transport activity was quantified as the AUC.
For each of the indicated proteins, the obtained AUCwere normalized to their respective average plasmamembrane expression levels (Fig. 9) and expressed
as percentage of the transport recorded for ZIP2WT in standard uptake buffer (KB buffer), pH 6.5. Data from four independent experiments (n 25–53) were
pooled together and represented asmean S.D. Statistical differenceswere assessed as describedpreviously (Cd2uptake in the absence versus thepresence
of 140 mM K); ns, p 0.05; *, p 0.05; ***, p 0.001.
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tion, as opposed to members of the LIV-1 subfamily
(SLC39A4–8, SLC39A10, and SLC39A12–14 (4)) as well as
bbZIP. In addition, although likely not directly participating in
substrate binding, the nearby residue Phe-269 seems to affect
substrate selectivity, possibly by regulating the size of the access
path to the substrate-binding site. When comparing the two
models of human ZIP2 presented here, even though they are
very similar overall, we believe that the bbZIP-based model
recapitulates the geometry of the proposed binding site better
than the apo old model, because it presumes that there is
already a bound divalent metal ion substrate. Based on our
experimental findings and the underlying crystallographic data,
we believe that our new model represents the inward-open
state of human ZIP2 more precisely and reliably.
Residues shaping the pH sensitivity of transport
Apart from the residues near the proposed substrate-binding
site, we have identified several other residues that affect the pH
sensitivity of transport in ZIP2 aswell as its apparent affinity for
protons. The most prominent one is His-63, the loss of which
renders the transporter completely pH-insensitive. In addition,
mutations of Glu-67 and Phe-269, the two residues tested that
are closest to His-63, also affect apparent proton affinity and
thus pH sensitivity of transport (Fig. 5C). We therefore suspect
thatHis-63 and its vicinity (includingGlu-67 and Phe-269) rep-
resent a functional hot spot within the protein structure. How-
ever, based on our structural model and pKa estimations,
His-63 is probably not protonated in the inward-open state of
human ZIP2. Based on its location, we propose that His-63 is
part of an extracellular gate, the closing probability of which
might be enhanced by elevated H concentration. In general,
we suggest that transport by ZIP2 is very sensitive to local elec-
trostatic perturbations, such as in the case of membrane depo-
larization or protonation changes. Our pKa estimations show
that there could be electrostatic cross-talk between the extra-
cellular gate and the substrate-binding site, whereas mutations
of charged residues around the substrate-binding site (Lys-203
and Glu-276) alter pH sensitivity and transport efficiency. We
also suggest that Glu-70, Glu-71, and Glu-120 are constantly
protonated, based on pKa estimation and the fact that their
glutamine-substituted variants display WT-like pH sensitivity.
Interestingly, mutations of Glu-106 also affected apparent pro-
ton affinity and pH sensitivity of transport. A hypothetical
dimeric structure suggests that Glu-73, Glu-101, and Glu-106
might form a cluster of acidic residues with a possible func-
tional role. We propose that this site might be a sensor for
extracellular proton concentration, or possibly a lipid-binding
site, exerting its functional role by the allosteric stabilization of
the extracellular gate (Fig. 8C). However, because neither
Glu-73 nor Glu-101 were tested in our study, this hypothesis
warrants further investigation.
Table 1
Estimated pKa values of selected side chains of ZIP2
Values have been calculated both in the presence and absence of a Zn2 ion substrate, in wildtype protein, and upon H63A, K203A, and K203R substitutions. 	pKa shifts
denote differences between apo and Zn2-bound pKa values. Residues with shaded background were protonated during the calculations. Values marked with an asterisk
correspond to the Arg-203 side chain of the K203R variant. The full list of pKa values for all side chains can be found in Table S1.
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Possible transport mechanism based on internal symmetry
considerations
The structural fold of ZIP transporters bears the “3 2 3”
TMH organization and shows an internal structural symmetry
(4), which potentially provides a structural basis for an alternat-
ing-access transport mechanism (29). We believe that such a
mechanism would be better supported, compared with a chan-
nel-like mechanism, by the following facts: 1) substrate trans-
port through ZIPs is saturable; 2) the bbZIP structure is closed
on the extracellular side with no visible pore-like structures;
and 3) a well-defined substrate-binding site is present. Although
the bbZIP protein was crystallized in an inward-open conforma-
tion, themodel of humanZIP4 byAntala et al. (5) seems to be in a
substrate-free occluded state, with both extracellular and intracel-
lular gates closed. The latter could be an artificial state due to
model construction (30)andmightbe lessphysiologically relevant.
Interestingly, it exhibits a conformation with features of both
inward-facing andoutward-facing states. For this reason, compar-
ison of the models of human ZIP2 based on these two structures
can be a valuable source of inspiration to derive hypotheses about
possible transport mechanisms. Notably, His-63 lies in a bulge
along TMH 2, which is likely present due to the helix-breaking
residuePro-110 inbbZIP. Such regions can representhingepoints
in the protein chain, suggesting that this region around His-63,
Glu-67, and Glu-262 might undergo rearrangements during the
opening of the extracellular gate. Consistent with this, the residue
equivalent toHis-63 in the other symmetric half of the transporter
(given the internal structural symmetry) is Glu-276. According to
our observations, this residue directly coordinates the metal ion
substrate.Thus,Glu-276mightconstitutean intracellulargate, the
dislocation of which could disrupt the substrate-binding site and
enable the solvation of the bound substrate ion. Residues down-
stream of Glu-276 also include a helix-breaking residue (Pro-279)
and are probably disordered in the inward-facing state, as their
coordinates could not be resolved in the bbZIP structure. A com-
parison of our two ZIP2 models also shows that the intracellular
half of TMH 4 is significantly more open in the bbZIP-based
model, indicating that this region could be part of the intracellular
gate as well. The apparent hinge point lies around His-175 in
human ZIP2, which binds one of the five additional Zn2 ions in
the bbZIP structure, alongwith the residue corresponding toGlu-
276. Based onour oldZIP2model, we propose that, in a substrate-
bound inward-closed state, both His-175 and Glu-276 bind the
central Zn2 substrate and that intracellular closure is achievedby
the-helical reorganizationof residues277–283andtheclosureof
the intracellular parts ofTMH4andTMH7. In turn, based on the
symmetry considerations, the extracellular half of TMH 5 posi-
tioned vis a` visHis-63 is expected to form part of the extracellular
gate as the symmetry pair of TMH 4. In this case, His-202 would
constitute a hinge point, where amarked kink inTMH5 is already
evident. The residue corresponding to His-63 in bbZIP (Ser-106)
was suggested to play a role in guiding metal substrate into the
transportpathway (7),whereasalaninesubstitutionofHis-379, the
corresponding residue in humanZIP4, severely reduced transport
activity (5). These considerations underline our hypothesis that
stabilization of the region around His-63 (including Glu-67 and
Glu-262) via protonation could contribute to the closure of the
extracellular gate, constituting a possible mechanism of how pro-
ton concentration could affect the transport rate. In addition, the
integrity of the hot spot around His-63 seems to be important for
voltage-modulated transport via human ZIP2, because mutations
in this region (H63A,E67A/E67Q, andF269L) lose their sensitivity
to depolarizing conditions (Fig. 7). This might also indicate that
charged residues in the region (e.g. Glu-67 or possibly also Glu-
262) are mobile and that their rearrangement upon changes in
membrane potential directly affects the rate of transport. There-
fore, based on our experimental evidence, we propose that the
stability of this functional hot spot is a key aspect in the transport
cycle, and thus, theelements that can influence thearrangementof
this particular region, as protonation state or charge distribution,
areable to influence the transport rate throughZIP2.Further stud-
ies will be required to clarify the exact role of these hot spot resi-
dues in the overall transport mechanism of ZIP2.
Experimental procedures
Materials
All chemicals and reagents were purchased from Sigma
except when mentioned specifically.
Human ZIP2 single-pointmutant generation
Amino acid residues present in His-63, Glu-67, Glu-70, Glu-
71, Glu-106, Glu-120, His-175, Ser-176, Glu-179, His-202, and
Phe-269 as well as Lys-203, Ser-235, andGlu-276weremutated
by PCR amplification of the human WT pIRES2-DsRed-ZIP2
construct (13) using primers (sequences available upon request)
designed to replace these residues as follows:Glu toAlaorGln;His
to Ala, Gln, or Glu; Lys to Ala, Gln, or Arg; Ser to Ala; and Phe to
Ala or Leu. Obtained PCR products were used to transformXL1-
Blue MRF super-competent cells (Agilent Technologies) by the
heat-shock method. Transformed cells were selected in LB-agar
plates containing 30 g/ml kanamycin. DNA from single-clone
colonieswas isolatedandsequenced (MicrosynthAG) toverify the
proper insertion of the designedmutations.
Cell culture
HEK293were obtained fromAmericanTypeCulture Collec-
tion (ATCC, Manassas, VA). HEK293 cells were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Invitrogen)
supplemented with 10% fetal bovine serum, 10 mM HEPES, 1
mM sodium pyruvate (Gibco), and 0.1 mM nonessential amino
acids in a cell culture incubator under standard conditions for
mammalian cells (37 °C; 5% CO2).
Transient transfection
HEK293 cells were plated on poly-D-lysine–coated 6 wells (2
ml of 500,000 cells/ml solution per well) or 96 wells (100 l of
300,000 cells/ml solution per well). After 24 h, cells were trans-
fectedwith the desiredDNAconstruct and Lipofectamine 2000
(Invitrogen), following the instruction described in themanufa-
cturer’s protocol. 6 h after the transfection, the medium was
completely replaced by fresh DMEM. The subsequent experi-
ments were performed 24 h after the transfection.
Cell-surface biotinylation andWestern blotting
Transiently transfected HEK293 cells (6-well plates) were
rinsed with PBS and incubated with 1.5 mg/ml sulfo-NHS-SS-
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biotin for 1 h at 4 °C. Next, cells were washed with PBS buffer
supplemented with 1 mM MgCl2, 0.1 mM CaCl2, and 100 mM
glycine and then newly rinsedwith PBS. Finally, cells were lysed
with radioimmunoprecipitation assay buffer (RIPA) (150 mM
NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% deoxycholate, 0.1%
SDS, 50 mM Tris-HCl, pH 7.4) containing fresh protease inhib-
itor mixture (Roche Applied Science). Cell lysates were equili-
brated overnight at 4 °C with streptavidin-agarose beads equiv-
alent to the protein content of the lysates. Next day, beads were
washed and recovered by centrifugation. Biotinylated proteins
were released from the beads by heating to 95 °Cwith 2
Laem-
mli buffer, separated on SDS-polyacrylamide gels, and trans-
ferred onto Immobilion-P membrane blots (Millipore). Blots
were incubated sequentially with primary and secondary anti-
bodies, and proteins were revealed by enhanced chemilumines-
cence method (ECL). Primary antibodies used were as follows:
rabbit polyclonal anti-SLC39A2 antibody (1:500 dilution)
(Abcam); mousemonoclonal anti-Na/H exchanger 1 antibody
(1:1000) (Merck Millipore); and mouse monoclonal anti--actin
(1:100dilution) (SantaCruzBiotechnology). Secondary antibodies
used were as follows: HRP-conjugated goat anti-mouse IgG
(1:3000) (Bio-Rad) and goat anti-rabbit IgG (1:20,000) (Promega).
To verify the equal loading among samples, all the biotinylated
proteins were visualizedwith avidin–HRP conjugate (1:1000 dilu-
tion) (Bio-Rad). To assess the expression of eachof the transfected
proteins, densitometry determination of the visualized bands
was performed using the ImageJ software (National Institutes of
Health) (31).
Intracellular cadmium accumulationmeasurements by
real-time fluorescence imaging
After removing the culture medium, transient transfected
HEK293 cells (poly-D-lysine–coated 96-well, clear bottom,
black plates) were loaded with 50 l of calcium 5 fluorescent
dye (Molecular Devices) dissolved in uptake buffer (117 mM
NaCl, 4.8 mM KCl, 1 mM MgCl2, 10 mM glucose, 5 mM HEPES,
5 mM MES, pH 7.4) at 37 °C for 1 h. Next, Cd2 accumulation
was determined by quantifying the fluorescence signal (excita-
tion, 470–495 nm; emission, 515–575 nm), a consequence of
the binding of internalized Cd2 to the intracellular Calcium 5
dye using a FLIPRTetramicroplate reader (MolecularDevices).
In each experiment, a baseline was recorded for 50 s, and then,
50 l of uptake buffer containing 2
 [Cd2] (0.1–10 M) were
added, and changes in fluorescence intensity were recorded for
15 min. To quantify the transport activity mediated by the
transfected ZIP2 variants, the area under the curve of the fluo-
rescence signal recorded between the Cd2 perfusion step and
the end of the experiments was calculated. For the pH-depen-
dence experiments, pH levels were adjusted with 1 N HCl/
NaOH. For the metal competition experiments, high concen-
trations (50 M) of the tested divalent metals (Zn2, Cu2,
Co2, Mn2, and Ba2) were perfused together with Cd2 (1
M).When studying the effect of [K] on the transport activity
of ZIP2 variants, in the uptake buffer [NaCl] was replaced by
equimolar [KCl].
Radiolabeled iron uptake
These experiments were conducted as described previously
(32). Briefly,media were removed from the culture plates (poly-
D-lysine–coated 96-well, clear bottom, white plates), and the
cells were rinsed three times with uptake buffer (140 mMNaCl,
2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1.2 mM K2HPO4, 100
mM glucose, 5 mMHEPES, 5 mMMES, pH 7.4). Then, 100 l of
uptake buffer containing 1 M nonradioactive FeCl2, 1 mM
ascorbic acid, and 0.5 Ci/ml radioactive 55Fe (American
Radiolabeled Chemicals, St. Louis, MO) were added into each
well. Cells were incubated at room temperature for 15min, and
the uptake was stopped by washing the plates three times with
ice-cold uptake buffer. Finally, 100 l of Microscint 20
(PerkinElmer Life Sciences) were added to each well, and the
uptake activity was determined as counts/min using a Top-
Count Microplate Scintillation Counter (PerkinElmer Life
Sciences).
Structural modeling and sequence alignments
The alignment of the human SLC39/ZIP family and bbZIP
was generated using PSI-COFFEE 11.00.d625267 using default
settings on the server http://tcoffee.crg.cat/7 (33, 34). The com-
plete alignment can be found in Fig. S1. The Uniprot sequence
Q9NP94 (isoform 1) was used for modeling human ZIP2. The
first ZIP2 model was generated based on the published struc-
tural model of human ZIP4 by Antala et al. (5), using Rosetta
(35) version 2016.20.58704. First, a sequence alignment
between the ZIP4 model and ZIP2 was generated using Clust-
alW (36), and then the human ZIP2 sequence was threaded 100
times on the human ZIP4 model using the “fixbb” program of
Rosetta with default settings. The model with the best Rosetta
score (“talaris2014” scoring function) was selected and opti-
mized using the “fast_relax” protocol with “repeats” set to 8
using the “relax” tool of Rosetta (37), in 10 independent runs. In
this step, transmembrane segments as predicted by theMESSA
consensus server (38) were taken into account, and the
“mpframework_smooth_fa_2012” scoring function (39) was used
to mimic the membrane environment around the protein. In the
above-mentioned protocol, dimeric symmetry restraints were
applied throughout. Finally, the model with the best score was
selected. For modeling the structure of human ZIP2 based on
bbZIP, MODELLER 9.17 (40) was used with default settings, and
an alignment between the sequence of the bbZIP structure (Pro-
tein Data Bank code 5TSA (7)) and human ZIP2 was generated
using AlignMe (41). Secondary structure restraints were added to
keep residues 24–33 and 67–83 in an -helical conformation
based on secondary structure prediction by the PSIPRED 3.3
server (42, 43). 50models were generated, and themodel with the
lowestMODELLER objective function score was selected.
pKa calculations
The pKa values of protein residue side chains were estimated
using PROPKA 3.1 (44, 45), followed by the calculation of pKa
shifts due to the membrane bilayer using APBSmem (45). The
initial protonation states for all titratable residues were chosen
based on PROPKA 3.1 predictions alone. Then, APBSmem cal-
culations were performed iteratively by adjusting the protona-
tion state of residues after each iteration based on the predicted
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pKa values until reaching self-consistency. In the iterative
scheme, residues with a predicted pKa higher than 6.5 were
protonated (corresponding to a pH of 6.5). For PROPKA 3.1,
default options were used. For APBSmem, the PARSE force-
field was used, 0.1 Mmonovalent counterions with 2.0 Å radius,
298.15 K temperature, and the dielectric constants of protein,
solvent, membrane, and headgroup were set to 10.0, 80.0, 2.0,
and 80.0, respectively. Membrane and headgroup thickness of
42.0 and 9.0 Åwere used, respectively, with themembrane bot-
tom at 21.0 Å. Calculations were performed with the npbe
method, Spl2 charge model, and three-step grid refinement as
described elsewhere (46).
Statistics
Normal distribution of the collected data groups was
assessed by Kolmogorov-Smirnov and Shapiro-Wilk tests (n
50 samples). Normally distributed sample groups were com-
pared using unpaired Student’s test, and the nonparametric
data groups were compared using the Mann-Whitney U test.
Statistical tests were performed using the IBM SPSS statistics
20 software. Significance level was set at p 0.05.
Author contributions—G. G., G. A., M. A. H., and J. P.-G. conceptu-
alization; G. G., G. A., D. G. F., and J. P.-G. data curation; G. G. soft-
ware; G. G., G. A., D. G. F., and J. P.-G. formal analysis; G. G.,
D. G. F., M. A. H., and J. P.-G. supervision; G. G., G. A., D. G. F.,
M. A. H., and J. P.-G. validation; G. G., G. A., D. G. F., and J. P.-G.
investigation; G. G., G. A., D. G. F., M. A. H., and J. P.-G. visualiza-
tion; G. G., G. A., D. G. F., and J. P.-G. methodology; G. G., G. A.,
D. G. F., M. A. H., and J. P.-G. writing-original draft; G. G., G. A.,
D. G. F., M. A. H., and J. P.-G. writing-review and editing; D. G. F.,
M. A. H., and J. P.-G. resources; D. G. F. andM. A. H. funding acqui-
sition; M. A. H. and J. P.-G. project administration.
Acknowledgments—We thank Drs. Marie Christine Franz and Mark
Hilge for their contributions toward the preliminary experiments that
served as a starting point for this research project. We also acknowl-
edge Tamara Locher and Yvonne Amrein for their dedication and
technical support.
References
1. Bafaro, E., Liu, Y., Xu, Y., and Dempski, R. E. (2017) The emerging role of
zinc transporters in cellular homeostasis and cancer. Signal Transduct.
Target Ther. 2, 17029 CrossRef Medline
2. Baltaci, A. K., and Yuce, K. (2018) Zinc transporter proteins. Neurochem.
Res. 43, 517–530 CrossRef Medline
3. Kambe, T., Tsuji, T., Hashimoto, A., and Itsumura, N. (2015) The physi-
ological, biochemical, and molecular roles of zinc transporters in zinc
homeostasis andmetabolism.Physiol. Rev. 95, 749–784CrossRefMedline
4. Jeong, J., and Eide, D. J. (2013) The SLC39 family of zinc transporters.Mol.
Aspects Med. 34, 612–619 CrossRef Medline
5. Antala, S., Ovchinnikov, S., Kamisetty, H., Baker, D., and Dempski, R. E.
(2015) Computation and functional studies provide a model for the struc-
ture of the zinc transporter hZIP4. J. Biol. Chem. 290, 17796–17805
CrossRef Medline
6. Lu, M., and Fu, D. (2007) Structure of the zinc transporter YiiP. Science
317, 1746–1748 CrossRef Medline
7. Zhang, T., Liu, J., Fellner, M., Zhang, C., Sui, D., and Hu, J. (2017) Crystal
structures of a ZIP zinc transporter reveal a binuclear metal center in the
transport pathway. Sci. Adv. 3, e1700344 CrossRef Medline
8. Gaither, L. A., and Eide, D. J. (2000) Functional expression of the human
hZIP2 zinc transporter. J. Biol. Chem. 275, 5560–5564 CrossRef Medline
9. Gaither, L. A., and Eide, D. J. (2001) The humanZIP1 transportermediates
zinc uptake in human K562 erythroleukemia cells. J. Biol. Chem. 276,
22258–22264 CrossRef Medline
10. He, L., Girijashanker, K., Dalton, T. P., Reed, J., Li, H., Soleimani, M., and
Nebert, D.W. (2006) ZIP8, member of the solute-carrier-39 (SLC39)met-
al-transporter family: characterization of transporter properties. Mol.
Pharmacol. 70, 171–180 CrossRef Medline
11. Girijashanker, K., He, L., Soleimani, M., Reed, J. M., Li, H., Liu, Z., Wang,
B., Dalton, T. P., and Nebert, D. W. (2008) Slc39a14 gene encodes ZIP14,
a metal/bicarbonate symporter: similarities to the ZIP8 transporter.Mol.
Pharmacol. 73, 1413–1423 CrossRef Medline
12. Lin, W., Chai, J., Love, J., and Fu, D. (2010) Selective electrodiffusion of
zinc ions in a Zrt-, Irt-like protein, ZIPB. J. Biol. Chem. 285, 39013–39020
CrossRef Medline
13. Franz, M. C., Simonin, A., Graeter, S., Hediger, M. A., and Kovacs, G.
(2014) Development of the first fluorescence screening assay for the
SLC39A2 zinc transporter. J. Biomol. Screen. 19, 909–916 CrossRef
Medline
14. Franz, M. C., Pujol-Gime´nez, J., Montalbetti, N., Fernandez-Tenorio, M.,
DeGrado, T. R., Niggli, E., Romero, M. F., and Hediger, M. A. (2018)
Reassessment of the transport mechanism of the human zinc transporter
SLC39A2. Biochemistry 57, 3976–3986 CrossRef Medline
15. Desouki, M. M., Geradts, J., Milon, B., Franklin, R. B., and Costello, L. C.
(2007) hZip2 and hZip3 zinc transporters are down regulated in human
prostate adenocarcinomatous glands.Mol. Cancer 6, 37CrossRefMedline
16. Rishi, I., Baidouri, H., Abbasi, J. A., Bullard-Dillard, R., Kajdacsy-Balla,
A., Pestaner, J. P., Skacel, M., Tubbs, R., and Bagasra, O. (2003) Prostate
cancer in African American men is associated with downregulation of
zinc transporters. Appl. Immunohistochem. Mol. Morphol. 11,
253–260 Medline
17. Franz, M. C., Anderle, P., Bu¨rzle, M., Suzuki, Y., Freeman, M. R., Hediger,
M. A., and Kovacs, G. (2013) Zinc transporters in prostate cancer. Mol.
Aspects Med. 34, 735–741 CrossRef Medline
18. Costello, L. C., Franklin, R. B., Zou, J., Feng, P., Bok, R., Swanson, M. G.,
and Kurhanewicz, J. (2011) Human prostate cancer ZIP1/zinc/citrate ge-
netic/metabolic relationship in the TRAMP prostate cancer animal
model. Cancer Biol. Ther. 12, 1078–1084 CrossRef Medline
19. Franklin, R. B., Feng, P., Milon, B., Desouki, M. M., Singh, K. K., Kajdacsy-
Balla, A., Bagasra, O., and Costello, L. C. (2005) hZIP1 zinc uptake trans-
porter down regulation and zinc depletion in prostate cancer.Mol. Cancer
4, 32 CrossRef Medline
20. Johnson, L. A., Kanak, M. A., Kajdacsy-Balla, A., Pestaner, J. P., and
Bagasra, O. (2010) Differential zinc accumulation and expression of hu-
man zinc transporter 1 (hZIP1) in prostate glands.Methods 52, 316–321
CrossRef Medline
21. Tao, Y. T., Huang, Q., Jiang, Y. L.,Wang, X. L., Sun, P., Tian, Y.,Wu, H. L.,
Zhang, M., Meng, S. B., Wang, Y. S., Sun, Q., and Zhang, L. Y. (2013)
Up-regulation of Slc39A2(Zip2) mRNA in peripheral blood mononuclear
cells from patients with pulmonary tuberculosis. Mol. Biol. Rep. 40,
4979–4984 CrossRef Medline
22. Hamon, R., Homan, C. C., Tran,H. B.,Mukaro, V. R., Lester, S. E., Roscioli,
E., Bosco, M. D., Murgia, C. M., Ackland, M. L., Jersmann, H. P., Lang, C.,
Zalewski, P. D., and Hodge, S. J. (2014) Zinc and zinc transporters in
macrophages and their roles in efferocytosis in COPD. PLoS ONE 9,
e110056 CrossRef Medline
23. Cao, J., Bobo, J. A., Liuzzi, J. P., and Cousins, R. J. (2001) Effects of intra-
cellular zinc depletion on metallothionein and ZIP2 transporter expres-
sion and apoptosis. J. Leukoc. Biol. 70, 559–566 Medline
24. Cousins, R. J., Blanchard, R. K., Popp,M. P., Liu, L., Cao, J.,Moore, J. B., and
Green, C. L. (2003) A global view of the selectivity of zinc deprivation and
excess on genes expressed in humanTHP-1mononuclear cells.Proc. Natl.
Acad. Sci. U.S.A. 100, 6952–6957 CrossRef Medline
25. Inoue, Y., Hasegawa, S., Ban, S., Yamada, T., Date, Y., Mizutani, H., Na-
kata, S., Tanaka, M., and Hirashima, N. (2014) ZIP2 protein, a zinc trans-
porter, is associated with keratinocyte differentiation. J. Biol. Chem. 289,
21451–21462 CrossRef Medline
26. Hara, T., Takeda, T. A., Takagishi, T., Fukue, K., Kambe, T., and Fukada, T.
(2017) Physiological roles of zinc transporters: molecular and genetic im-
Structural basis of transport in SLC39A2
8062 J. Biol. Chem. (2019) 294(20) 8046–8063
 at U
niversitaetsbibliothek Bern on July 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
portance in zinc homeostasis. J. Physiol. Sci. 67, 283–301 CrossRef
Medline
27. Wang, C. Y., Jenkitkasemwong, S., Duarte, S., Sparkman, B. K., Shawki, A.,
Mackenzie, B., and Knutson, M. D. (2012) ZIP8 is an iron and zinc trans-
porter whose cell-surface expression is up-regulated by cellular iron load-
ing. J. Biol. Chem. 287, 34032–34043 CrossRef Medline
28. Jenkitkasemwong, S., Wang, C. Y., Mackenzie, B., and Knutson, M. D.
(2012) Physiologic implications ofmetal-ion transport by ZIP14 and ZIP8.
Biometals 25, 643–655 CrossRef Medline
29. Forrest, L. R., Kra¨mer, R., and Ziegler, C. (2011) The structural basis of
secondary active transport mechanisms. Biochim. Biophys. Acta 1807,
167–188 CrossRef Medline
30. Hopf, T. A., Colwell, L. J., Sheridan, R., Rost, B., Sander, C., and Marks,
D. S. (2012) Three-dimensional structures of membrane proteins from
genomic sequencing. Cell 149, 1607–1621 CrossRef Medline
31. Schneider, C. A., Rasband, W. S., and Eliceiri, K. W. (2012) NIH Image to
ImageJ: 25 years of image analysis. Nat. Methods 9, 671–675 CrossRef
Medline
32. Pujol-Gime´nez, J., Hediger, M. A., and Gyimesi, G. (2017) A novel proton
transfer mechanism in the SLC11 family of divalent metal ion transport-
ers. Sci. Rep. 7, 6194 CrossRef Medline
33. Di Tommaso, P., Moretti, S., Xenarios, I., Orobitg, M., Montanyola, A.,
Chang, J. M., Taly, J. F., and Notredame, C. (2011) T-Coffee: a web server
for the multiple sequence alignment of protein and RNA sequences using
structural information and homology extension. Nucleic Acids Res. 39,
W13–W17 CrossRef Medline
34. Kemena, C., and Notredame, C. (2009) Upcoming challenges for multiple
sequence alignment methods in the high-throughput era. Bioinformatics
25, 2455–2465 CrossRef Medline
35. Kuhlman, B., Dantas, G., Ireton, G. C., Varani, G., Stoddard, B. L., and
Baker, D. (2003) Design of a novel globular protein fold with atomic-level
accuracy. Science 302, 1364–1368 CrossRef Medline
36. Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan,
P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R.,
Thompson, J. D., Gibson, T. J., and Higgins, D. G. (2007) Clustal W and
Clustal X version 2.0. Bioinformatics 23, 2947–2948 CrossRef Medline
37. Nivo´n, L. G., Moretti, R., and Baker, D. (2013) A Pareto-optimal refine-
ment method for protein design scaffolds. PLoS ONE 8, e59004 CrossRef
Medline
38. Cong, Q., and Grishin, N. V. (2012) MESSA: MEta-server for protein
sequence analysis. BMC Biol. 10, 82 CrossRef Medline
39. Alford, R. F., Koehler Leman, J., Weitzner, B. D., Duran, A. M., Tilley,
D. C., Elazar, A., and Gray, J. J. (2015) An integrated framework advancing
membrane protein modeling and design. PLoS Comput. Biol. 11,
e1004398 CrossRef Medline
40. Webb, B., and Sali, A. (2014) Comparative protein structure modeling
using MODELLER. Curr. Protoc. Bioinformatics 47, 5.6.1–32 CrossRef
Medline
41. Stamm,M., Staritzbichler, R., Khafizov, K., and Forrest, L. R. (2013) Align-
ment of helicalmembrane protein sequences usingAlignMe.PLoSONE 8,
e57731 CrossRef Medline
42. Buchan, D. W., Minneci, F., Nugent, T. C., Bryson, K., and Jones, D. T.
(2013) Scalable web services for the PSIPRED protein analysis workbench.
Nucleic Acids Res. 41,W349–W357 CrossRef Medline
43. Jones, D. T. (1999) Protein secondary structure prediction based on posi-
tion-specific scoring matrices. J. Mol. Biol. 292, 195–202 CrossRef
Medline
44. Søndergaard, C. R., Olsson,M.H., Rostkowski,M., and Jensen, J. H. (2011)
Improved treatment of ligands and coupling effects in empirical calcula-
tion and rationalization of pKa values. J. Chem. Theory Comput. 7,
2284–2295 CrossRef Medline
45. Olsson,M.H., Søndergaard, C. R., Rostkowski,M., and Jensen, J. H. (2011)
PROPKA3: consistent treatment of internal and surface residues in em-
pirical pKa predictions. J. Chem. Theory Comput. 7, 525–537 CrossRef
Medline
46. Marcoline, F. V., Bethel, N., Guerriero, C. J., Brodsky, J. L., and Grabe, M.
(2015) Membrane protein properties revealed through data-rich electro-
statics calculations. Structure 23, 1526–1537 CrossRef Medline
47. Lomize, M. A., Lomize, A. L., Pogozheva, I. D., and Mosberg, H. I. (2006)
OPM: orientations of proteins inmembranes database. Bioinformatics 22,
623–625 CrossRef Medline
Structural basis of transport in SLC39A2
J. Biol. Chem. (2019) 294(20) 8046–8063 8063
 at U
niversitaetsbibliothek Bern on July 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Pujol-Giménez
Gergely Gyimesi, Giuseppe Albano, Daniel G. Fuster, Matthias A. Hediger and Jonai
human zinc transporter SLC39A2 (ZIP2)
Unraveling the structural elements of pH sensitivity and substrate binding in the
doi: 10.1074/jbc.RA118.006113 originally published online March 26, 2019
2019, 294:8046-8063.J. Biol. Chem. 
  
 10.1074/jbc.RA118.006113Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/294/20/8046.full.html#ref-list-1
This article cites 47 references, 12 of which can be accessed free at
 at U
niversitaetsbibliothek Bern on July 15, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
